Induction of HIV-1 specific mucosal immune responses by DNA vaccination

Scandinavian Journal of Immunology

Volumn 46, Issue 4, 1997, Pages 326-330

  Asakura, Y ^a   Hinkula, J ^a   Leandersson, A C ^a   Fukushima, J ^b   Okuda, K ^b   Wahren, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION;

EID: 0030847887     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-146.x     Document Type: Article

References (32)

1. Cox GJM, Zamb TJ, Babiuk LA. Bovine herpes virus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol 1993;67:5664-7.
2. Boyer JD, Ugen KE, Wang B et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997;3:526-32.
3. Donelly JJ, Friedman A, Martinez D et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1995;1:583-7.
4. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunization by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-82.
5. Manickan E, Rouse RJD, Yu Z, Wire WS, Rouse BT. Genetic immunization against herpes simplex virus. J Immunol 1995;155:259-65.
6. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993;11:957-60.
7. Ulmer JB, Donelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
8. Webster RG, Fynan EF, Santoro JC, Robinson HL. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 1994;12:1495-8.
9. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HCJ. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994;199:132-40.
10. McDonnell WM, Askari FK. DNA vaccines. New Engl J Med 1996;344:42-5.
11. Wahren B. Gene vaccines. Immunotechnology 1996;2:77-83.
12. Wolff JA., Malon RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
13. Okuda K, Bukawa H, Hamajima K et al. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retroviruses 1995;11:933-43.
14. Hinkula J, Lundholm P, Wahren B. Nucleic acid vaccination with HIV regulatory genes: A combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine 1997;15:874-8.
15. Wahren B, Hinkula J, Ljungdahl SE, Borrebaeck C, Schwartz S, Wigzell H. Nucleic acid vaccination with HIV regulatory genes. Ann New York Acad Sci 1995;772:278-81.
16. Hinkula J, Svanholm C, Schwartz S et al. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol 1997;71:5528-39.
17. Wahren B, Brytting M, Engström G et al. Immune responses to the HIV-1 rev regulatory gene. Antibiot Chemother 1996;48:105-12.
18. Cullen BR. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986;46:973-82.
19. Lukkonen BGM, Fenyö EM, Schwartz S. Overexpression of the human immunodeficiency virus type 1 protease increases intracellular cleavage of gag and reduces virus infectivity. Virology 1995;206:854-65.
20. Schwartz S, Campbell M, Nascioulas G, Harrison J, Felber BK, Pavlakis GN. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 1992;66:7176-82.
21. Wahren B, Bratt G, Persson C et al. Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:220-9.
22. Brandtzaeg P. Overview of the mucosal immune system. Current Topics Microbiol Immunol. 1989;146:13-25.
23. Sirko DA, Ehrlich, GD. Genotypic and phenotypic characterization of a neutralization-resistent breakthrough population of HIV-1. Virology 1996;218:238-42.
24. Koenig S, Conley AJ, Brewah YA et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med 1995;1:330-6.
25. Broliden PA, Ljunggren K, Hinkula J, Norrby E, Åkerblom L, Wahren B. A monoclonal antibody to HIV-1 mediating cellular cytotoxicity (ADCC) and neutralization. J Virol 1990;64:936-40.
26. Adachi A, Koenig S, Gendelman HE et al. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol 1987;61:209-13.
27. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992;89:6901-5.
28. Mestecky J, Kutteh WH, Jackson S. Mucosal immunity in the female genital tract: Relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res Hum Retroviruses 1994;10: S11-S20.
29. Gallatin M, St.John TP, Siegelman M, Reichert R, Butcher EC, Weissman IL. Lymphocyte homing receptors. Cell 1986;44:673-80.
30. Mestecky J. The common mucosul immune system and current strategy for induction of immune responses in external secretions. J Clin Immunol 1987;7:265-76.
31. Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995;270:299-302.
32. Berggren RE, Wunderlich A, Ziegler E et al. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:489-95.